Skip to content

Clinical study of ketoprofen gel paste for pain relief in osteoarthritis: a randomized controlled trial

Clinical study of ketoprofen gel paste for pain relief in osteoarthritis: a randomized controlled trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091706
Enrollment
Unknown
Registered
2024-11-01
Start date
2024-11-03
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis

Interventions

Group B:Celecoxib
Group C:Ketoprofen Cataplasms+Celecoxib

Sponsors

Zhejiang Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) The subjects voluntarily agree to participate in the study and sign a written informed consent; (2) Age 18-75 years old, male or female; (3) According to clinical diagnosis, the patient has been diagnosed with unilateral osteoarthritis. According to the Kellgren Lawrence imaging grading, grades 0 to I belong to the early stage; Grade II-III belongs to the mid-term stage; Grade IV belongs to the late stage, and this study selected grades II-III with VAS>40mm; (4) No previous bleeding, asthma, severe cardiac, liver and renal insufficiency, non-steroidal drug allergy history;

Exclusion criteria

Exclusion criteria: (1) previous treatment that may affect the efficacy; (2) Patients with open wounds, scars or ulcers in the gel paste application area; (3) There are fractures, dislocations, etc. present; Accompanied by serious primary diseases such as tumors, cardiovascular and cerebrovascular diseases, hematological disorders, or accompanied by mental illness and communication disorders, the efficacy cannot be determined. Radiation pain or activity disorders caused by other diseases (visceral organ lesions, cardiovascular and cerebrovascular diseases); (4) Pregnant and lactating women or women of childbearing age who are trying to conceive; (5) Other situations in which the researcher considers it inappropriate to participate in this experiment.

Design outcomes

Primary

MeasureTime frame
Effective rate;

Secondary

MeasureTime frame
VAS score;WOMAC score;Knee Lysholm score;Adverse reaction observation;

Countries

China

Contacts

Public ContactTong Peijian

Zhejiang Hospital of Traditional Chinese Medicine

754746206@qq.com+86 137 0830 2754

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026